Remove tag social
article thumbnail

PharmaShots Weekly Snapshots (May 01 - 05, 2023)

PharmaShots

Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive EC’s Marketing Authorization of PRX-102 (pegunigalsidase alfa) for the Treatment of Fabry Disease Date: May 05, 2023 | Tags: Chiesi Global Rare Diseases, Protalix BioTherapeutics, PRX-102, pegunigalsidase alfa, Fabry Disease, Regulatory, EC, Marketing Authorization Kinoxis Therapeutics (..)

FDA 40
article thumbnail

5 Ways Your Pharmacy Can Participate in Parkinson’s Awareness Month

Digital Pharmacist

Utilize Your Pharmacy’s Social Media and Website Highlight Parkinson’s awareness through your pharmacy website offerings or on your social media platforms during the month of April. With it being so accessible to connect to patients virtually, utilizing social media is a fantastic way to spread awareness of PD to a wider audience.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Scientists and medics turn to TikTok to reassure public on vaccine safety

pharmaphorum

The social media platform, which allows users to share short and often frivolous video clips, has a growing number of experts using it to communicate important information to a broad audience, and particular teenagers and young adults. Dr Austin Chiang.

article thumbnail

What can pharma marketing learn from other regulated industries?

pharmaphorum

N o one industry is ever quite like another, but there are some valuable lessons for pharma marketing from examining how the financial sector uses technology, builds brands on social channels and approaches digital content. Sales calls that now have to start with a phone call are supported by digital and social content straightaway.

article thumbnail

Jolly Good/Teijin Pharma develop VR digital therapeutics for depression

pharmaphorum

Using technologies such as VR and AI, the company aims to accelerate human growth and social rehabilitation in medical education and provide support for people with disabilities, as well as provide treatments for mental illness. The post Jolly Good/Teijin Pharma develop VR digital therapeutics for depression appeared first on.

Hospitals 122
article thumbnail

IBM sells off large parts of Watson Health business

pharmaphorum

Francisco Partners is picking up a range of databases and analytics tools – including Health Insights, MarketScan, Clinical Development, Social Programme Management, Micromedex and other imaging and radiology tools – for an undisclosed sum estimated to be in the region of $1 billion.

Cerner 111
article thumbnail

I AM #NF2AWARE

NF2 BioSolutions

We have created a poster that you can print off, we would like everyone to get involved, take a selfie with the poster, or get someone else to take a photo of you and send it to us or post it onto your timeline (tag us please!). Or you can make a video saying, “I AM NF2 AWARE, ARE YOU?” (if ANYONE YOU CAN THINK OF!!

52